ALMS
Price:
$26.38
Market Cap:
$3.26B
Alumis Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of medicines for autoimmune disorders. The company offers envudeucitinib, a tyrosine kinase 2 (TYK2) inhibitor for the treatment of plaque psoriasis and systemic lupus erythematosus; and A-005, a central nervous system-penetrant allosteric TYK2 inhibitor that is in Phase 1 for the treatment of neuroinflammatory and neurodegenerative diseases. It also develops lonigutamab, a monoclonal antibody targeting IGF-1R for the treatment of thyroid eye diseases; and interferon regulatory factor 5 (IRF5) to address immune dysfunction. The company was formerly known as Esker Therapeutics, Inc. and c...[Read more]
Industry
Biotechnology
IPO Date
2024-06-28
Stock Exchange
NASDAQ
Ticker
ALMS
According to Alumis Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -6.73. This represents a change of 164.87% compared to the average of -2.54 of the last 4 quarters.
The mean historical PE Ratio of Alumis Inc. over the last ten years is -2.58. The current -6.73 PE Ratio has changed 26.03% with respect to the historical average. Over the past ten years (40 quarters), ALMS's PE Ratio was at its highest in in the June 2025 quarter at 0.96. The PE Ratio was at its lowest in in the March 2026 quarter at -7.44.
Average
-2.58
Median
-2.55
Minimum
-4.45
Maximum
-0.76
Discovering the peaks and valleys of Alumis Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 455.57%
Maximum Annual PE Ratio = -0.76
Minimum Annual Increase = -82.98%
Minimum Annual PE Ratio = -4.45
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -4.21 | 455.57% |
| 2024 | -0.76 | -82.98% |
| 2023 | -4.45 | 399.33% |
The current PE Ratio of Alumis Inc. (ALMS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-3.14
5-year avg
-2.58
10-year avg
-2.58
Alumis Inc.’s PE Ratio is greater than RAPT Therapeutics, Inc. (-29.87), less than Neumora Therapeutics, Inc. Common Stock (-1.24), less than ADC Therapeutics S.A. (-1.05), less than Ocugen, Inc. (-5.11), greater than Eton Pharmaceuticals, Inc. (-941.88), less than Omeros Corporation (8.98), less than Fulcrum Therapeutics, Inc. (-3.15), greater than Lexicon Pharmaceuticals, Inc. (-32.49), less than Bicycle Therapeutics plc (-1.23), less than Lineage Cell Therapeutics, Inc. (-3.84),
| Company | PE Ratio | Market cap |
|---|---|---|
| -29.87 | $959.26M | |
| -1.24 | $305.72M | |
| -1.05 | $139.91M | |
| -5.11 | $402.84M | |
| -941.88 | $1.32B | |
| 8.98 | $844.62M | |
| -3.15 | $195.88M | |
| -32.49 | $1.03B | |
| -1.23 | $267.86M | |
| -3.84 | $264.26M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alumis Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Alumis Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Alumis Inc.'s PE Ratio?
How is the PE Ratio calculated for Alumis Inc. (ALMS)?
What is the highest PE Ratio for Alumis Inc. (ALMS)?
What is the 3-year average PE Ratio for Alumis Inc. (ALMS)?
What is the 5-year average PE Ratio for Alumis Inc. (ALMS)?
How does the current PE Ratio for Alumis Inc. (ALMS) compare to its historical average?